Oncobone Therapeutics Ltd is an active company incorporated on 8 March 2021 with the registered office located in . Oncobone Therapeutics Ltd was registered 4 years ago.
Confirmation statement made on 22 April 2025 with updates
Submitted on 26 Apr 2025
Total exemption full accounts made up to 31 December 2024
Submitted on 24 Apr 2025
Statement of capital following an allotment of shares on 8 November 2022
Submitted on 22 Apr 2025
Statement of capital following an allotment of shares on 28 June 2022
Submitted on 22 Apr 2025
Registered office address changed from Smith House George Street Nailsworth Stroud GL6 0AG England to 10 Queen Street Place London EC4R 1AG on 4 October 2024
Submitted on 4 Oct 2024
Certificate of change of name
Submitted on 4 Sep 2024
Appointment of Ms Lorenza Maria Castellon as a director on 4 May 2024
Submitted on 16 May 2024
Termination of appointment of Tarquin David Fletcher Edwards as a director on 22 April 2024
Submitted on 3 May 2024
Micro company accounts made up to 31 December 2023
Submitted on 3 May 2024
Confirmation statement made on 22 April 2024 with updates